Es gab 50 kürzliche Insider-Transaktionen für Prelude Therapeutics Incorporated (PRLD), darunter 42 Käufe und 5 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $9.15M und die gesamten Insider-Verkäufe auf $27.91K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Brusky Sean P., Lim Bryant David, Scherle Peggy. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — PRLD
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-05 |
Brusky Sean P. |
Chief Business Officer |
Unbekannt |
275,000 |
- |
- |
- |
| 2026-02-04 |
Lim Bryant David |
CLO, CFO, Corp Sec. |
RSU-Zuteilung |
275,000 |
$2.30 |
$632.5K |
275,000 |
| 2026-02-04 |
Scherle Peggy |
Chief Scientific Officer |
RSU-Zuteilung |
230,000 |
$2.30 |
$529K |
230,000 |
| 2026-02-04 |
Vaddi Krishna |
CEO |
RSU-Zuteilung |
837,000 |
$2.30 |
$1.93M |
837,000 |
| 2026-02-04 |
Combs Andrew |
Chief Chemistry Officer |
RSU-Zuteilung |
230,000 |
$2.30 |
$529K |
230,000 |
| 2025-11-05 |
Sandor Victor |
Director |
RSU-Zuteilung |
121,285 |
$1.39 |
$168.59K |
121,285 |
| 2025-10-17 |
Dorton Katina |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-10-04 |
Huang Jane |
President, CMO |
Optionsausübung (Verkauf) |
9,375 |
- |
- |
18,750 |
| 2025-07-04 |
Huang Jane |
President, CMO |
Optionsausübung (Verkauf) |
9,375 |
- |
- |
28,125 |
| 2025-06-12 |
Friedman Paul A |
Director |
RSU-Zuteilung |
38,000 |
$1.04 |
$39.52K |
38,000 |
| 2025-06-12 |
Baker Bros. Advisors Lp |
10 Percent Owner |
RSU-Zuteilung |
76,000 |
$1.04 |
$79.04K |
76,000 |
| 2025-06-12 |
Babler Martin |
Director |
RSU-Zuteilung |
38,000 |
$1.04 |
$39.52K |
38,000 |
| 2025-06-12 |
Bonita David P |
10 Percent Owner |
RSU-Zuteilung |
38,000 |
$1.04 |
$39.52K |
38,000 |
| 2025-06-12 |
Dier Mardi |
Director |
RSU-Zuteilung |
38,000 |
$1.04 |
$39.52K |
38,000 |
| 2025-06-12 |
Sandor Victor |
Director |
RSU-Zuteilung |
38,000 |
$1.04 |
$39.52K |
38,000 |
| 2025-06-12 |
Scherer Paul C |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-04-04 |
Huang Jane |
President, CMO |
Optionsausübung (Verkauf) |
9,375 |
- |
- |
37,500 |
| 2025-03-25 |
Vaddi Krishna |
CEO |
Informierter Kauf |
675,000 |
$0.69 |
$467.44K |
1,999,296 |
| 2025-03-25 |
Combs Andrew |
Chief Chemistry Officer |
Informierter Kauf |
100,000 |
$0.69 |
$69.25K |
480,123 |
| 2025-03-21 |
Vaddi Krishna |
CEO |
Informierter Kauf |
15,000 |
$0.73 |
$10.96K |
1,324,296 |
| 2025-03-20 |
Vaddi Krishna |
CEO |
Informierter Kauf |
5,416 |
$0.73 |
$3.95K |
1,309,296 |
| 2025-03-17 |
Vaddi Krishna |
CEO |
Informierter Kauf |
9,106 |
$0.75 |
$6.83K |
1,303,880 |
| 2025-03-14 |
Vaddi Krishna |
CEO |
Informierter Kauf |
29,999 |
$0.75 |
$22.63K |
1,294,774 |
| 2025-03-13 |
Vaddi Krishna |
CEO |
Informierter Kauf |
50,000 |
$0.72 |
$35.82K |
1,264,775 |
| 2025-03-12 |
Vaddi Krishna |
CEO |
Informierter Kauf |
47,500 |
$0.71 |
$33.74K |
1,214,775 |
| 2025-02-04 |
Huang Jane |
President, CMO |
RSU-Zuteilung |
200,000 |
$1.11 |
$222K |
200,000 |
| 2025-02-04 |
Lim Bryant David |
CLO, CFO, Corp Sec. |
RSU-Zuteilung |
200,000 |
$1.11 |
$222K |
200,000 |
| 2025-02-04 |
Scherle Peggy |
Chief Scientific Officer |
RSU-Zuteilung |
175,000 |
$1.11 |
$194.25K |
175,000 |
| 2025-02-04 |
Vaddi Krishna |
CEO |
RSU-Zuteilung |
496,000 |
$1.11 |
$550.56K |
496,000 |
| 2025-02-04 |
Combs Andrew |
Chief Chemistry Officer |
RSU-Zuteilung |
175,000 |
$1.11 |
$194.25K |
175,000 |
| 2025-01-04 |
Huang Jane |
President, CMO |
Optionsausübung |
9,375 |
- |
- |
46,875 |
| 2024-12-31 |
Vaddi Krishna |
CEO |
Informierter Kauf |
5,000 |
$1.21 |
$6.04K |
142,553 |
| 2024-12-30 |
Vaddi Krishna |
CEO |
Informierter Kauf |
10,000 |
$1.20 |
$12K |
137,553 |
| 2024-12-23 |
Combs Andrew |
Chief Chemistry Officer |
Informierter Kauf |
60,000 |
$1.37 |
$82K |
377,623 |
| 2024-12-20 |
Combs Andrew |
Chief Chemistry Officer |
Informierter Kauf |
3,075 |
$1.15 |
$3.54K |
317,623 |
| 2024-12-19 |
Lim Bryant David |
CLO, Interim CFO, Corp Sec. |
Informierter Kauf |
25,000 |
$0.91 |
$22.64K |
27,400 |
| 2024-12-19 |
Vaddi Krishna |
CEO |
Informierter Kauf |
6,888 |
$0.89 |
$6.12K |
127,553 |
| 2024-12-18 |
Vaddi Krishna |
CEO |
Informierter Kauf |
100,000 |
$0.93 |
$93.21K |
1,167,275 |
| 2024-07-04 |
Huang Jane |
President, CMO |
RSU-Steuereinbehalt |
3,347 |
$3.60 |
$12.05K |
57,315 |
| 2024-06-14 |
Friedman Paul A |
Director |
RSU-Zuteilung |
23,500 |
$3.90 |
$91.65K |
23,500 |
| 2024-06-14 |
Baker Bros. Advisors Lp |
10 Percent Owner |
RSU-Zuteilung |
23,500 |
$3.90 |
$91.65K |
23,500 |
| 2024-06-14 |
Babler Martin |
Director |
RSU-Zuteilung |
23,500 |
$3.90 |
$91.65K |
23,500 |
| 2024-06-14 |
Bonita David P |
10 Percent Owner |
RSU-Zuteilung |
23,500 |
$3.90 |
$91.65K |
23,500 |
| 2024-06-14 |
Dier Mardi |
Director |
RSU-Zuteilung |
23,500 |
$3.90 |
$91.65K |
23,500 |
| 2024-06-14 |
Sandor Victor |
Director |
RSU-Zuteilung |
23,500 |
$3.90 |
$91.65K |
23,500 |
| 2024-05-14 |
Lim Bryant David |
CLO, Interim CFO, Corp Sec. |
RSU-Zuteilung |
25,000 |
$3.86 |
$96.5K |
25,000 |
| 2024-04-04 |
Huang Jane |
President, CMO |
RSU-Steuereinbehalt |
3,347 |
$4.74 |
$15.86K |
51,287 |
| 2024-03-01 |
Chardonnet Laurent |
Chief Financial Officer |
RSU-Zuteilung |
150,000 |
$4.59 |
$688.5K |
150,000 |
| 2024-03-01 |
Huang Jane |
President, CMO |
RSU-Zuteilung |
175,000 |
$4.59 |
$803.25K |
175,000 |
| 2024-03-01 |
Lim Bryant David |
Chief Legal Officer, Corp Sec. |
RSU-Zuteilung |
150,000 |
$4.59 |
$688.5K |
150,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
